Number (N = 66) | Percentage (%) | |
---|---|---|
Level of FPG to define DM: correct | 48 | 72.7 |
Level of FPG to define fasting hyperglycemia: correct | 6 | 9.1 |
Level of PPG to define DM: correct | 25 | 37.9 |
Level of PPG to define impaired glucose tolerance: correct | 18 | 27.3 |
Level of random glycemia to define DM: correct | 13 | 19.7 |
Can Glycated Hemoglobin be used to define diabetes: Yes | 58 | 87.9 |
Level of Glycated Hemoglobin to define diabetes (N = 58): correct | 19 | 32.8 |
Level of systolic blood pressure to define hypertension in a patient with DM: correct | 23 | 34.8 |
Level of diastolic blood pressure to define hypertension in a patient with DM: correct | 17 | 25.8 |
Frequently asked morphologic and biological exams | ||
Full blood count | 31 | 47.0 |
Serum urea | 49 | 74.2 |
Creatinemia | 55 | 83.3 |
Serum uric acid | 24 | 36.4 |
Urinary dip stick | 27 | 40.9 |
Total cholesterol | 33 | 50.0 |
HDL cholesterol | 43 | 65.2 |
Triglycerides | 28 | 42.4 |
Natremia | 12 | 18.2 |
Kaliemia | 19 | 28.8 |
Chloremia | 12 | 18.2 |
Calcemia | 13 | 19.7 |
Magnesemia | 9 | 13.6 |
Chest X ray | 7 | 10.6 |
Cardiac echography | 5 | 7.6 |
Echocardiogram | 18 | 27.3 |
Fundoscopy | 18 | 27.3 |
Correct (minimal) workup asked | 6 | 9.9 |
Used to recommend lifestyle modifications: Yes | 61 | 92.4 |
Used to refer diabetes patients to the nutritionist: Yes | 46 | 69.7 |
Physical examination during diabetes patients’ consultations: complete | 24 | 36.4 |
Type of drug usually prescribed in type 2 diabetes mellitus | ||
Generic | 14 | 21.2 |
Specialty | 9 | 13.6 |
Both | 35 | 53.1 |
Missing data | 8 | 12.1 |
Class of drugs frequently prescribed as first line treatment in type 2 diabetes mellitus management | ||
Biguanides | 51 | 77.3 |
Sulfonamides | 40 | 60.6 |
Glinids | 5 | 7.6 |
Glitazones | 3 | 4.5 |
Insulin | 1 | 1.5 |
Alpha-glycosidase inhibitors | 2 | 3.0 |
DPP-4 inhibitors | 1 | 1.5 |
Used to prescribe 2 or more anti-diabetic drugs in patients with uncomplicated type 2 diabetes mellitus: Yes | 34 | 51.5 |
Combinations usually prescribed (N = 34) | ||
Sulfonamide-Biguanide | 31 | 91.2 |
Sulfonamide-Glinid | 1 | 2.9 |
Sulfonamide-Insulin | 3 | 8.8 |
Biguanide-Glinid | 3 | 8.8 |
Biguanide-Insulin | 1 | 2.9 |
Biguanide-Alpha-glycosidase inhibitors | 1 | 2.9 |
Biguanide-DPP-4 inhibitors | 1 | 2.9 |
Type of drugs usually prescribed in patients presenting with a hyperglycemic emergency | ||
Oral anti-diabetics | 7 | 10.6 |
Insulin | 57 | 86.4 |
Missing data | 2 | 3.0 |
Used to manage comorbidities: Yes | 6 | 9.1 |
Follow-up appointments usually given to diabetes patients: Yes | 64 | 97.0 |
Frequency of appointments (N = 62) | ||
Every week | 15 | 22.7 |
Every two weeks | 17 | 25.8 |
Once in a month | 32 | 48.5 |
Usually seek for information on new guidelines regarding diabetes care: Yes | 51 | 77.3 |
Source of information (N = 51) | ||
Medical visitor | 39 | 76.5 |
Conferences | 20 | 39.2 |
Colleague | 20 | 39.2 |
Internet | 14 | 27.5 |
Scientific journals | 9 | 17.6 |
Willingness to participate in future workshops on DM: Yes | 65 | 98.5 |